期刊文献+

非酒精性脂肪性肝病与冠状动脉粥样硬化的关系 被引量:1

Association between the non-alcoholic fatty liver disease and coronary atherosclerosis
下载PDF
导出
摘要 目的探讨非酒精性脂肪性肝病与冠状动脉粥样硬化的关系。方法采用病例对照研究的方法,选取疑诊冠状动脉粥样硬化性心脏病并拟行冠状动脉造影术的患者为研究对象,其中59例诊断为非酒精脂肪性肝病(Non-alcoholic fatty liver disease,NAFLD)的患者为病例组,另外41例非NAFLD的患者为对照组。采用冠脉造影诊断冠状动脉粥样硬化性心脏病,并评估冠状动脉粥样硬化的严重度,同时检测体重、身高等一般资料以及转氨酶、血脂、血糖等生化指标。结果 NAFLD患者冠状动脉粥样硬化性心脏病的患病率高于对照组。同时,NAFLD患者的冠状动脉粥样硬化严重度评分(Gensini积分)也高于对照组。结论 NAFLD与冠状动脉粥样硬化具有密切关系。 Objective To explore the association between the non-alcoholic fatty liver disease (NAFLD) and coronary atherosclerosis. Methods A case control study performed, patients suspected coronary atherosclerotic heart disease included, coronary angiography done to diagnosis the coronary atherosclerosis, and assess the severity of coronary atherosclerosis. NAFLD were diagnosed in 59 patients, 41 cases of non-NAFLD patients defined as control group. The weight, height and other body information, transaminase, cholesterol, blood sugar and other biochemical markers were assessed. Results The prevalence of NAFLD was higher in the patients with coronary atherosclerosis than the control group. Meanwhile, the coronary atherosclerosis severity score (Gensini score) were higher in NAFLD patients than the control group. Conclusion There is significant association between NAFLD and coronary atherosclerosis.
出处 《中国现代医生》 2014年第23期111-113,共3页 China Modern Doctor
基金 浙江省自然科学基金(LY13H030012) 浙江省中医药科学研究基金计划(2010ZB127) 浙江省宁波市医学科技计划项目(2010B03)
关键词 非酒精性脂肪性肝病 冠状动脉粥样硬化 Non-alcoholic fatty liver disease Coronary atherosclerosis
  • 相关文献

参考文献1

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649. 被引量:1
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219. 被引量:1
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231. 被引量:1
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397. 被引量:1
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490. 被引量:1
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44. 被引量:1
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261. 被引量:1
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215. 被引量:1
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861. 被引量:1

共引文献1511

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部